Omeros | OMER - Current Assets

Stock Price
9.88
Daily Change
-0.42 -4.08%
Monthly
-17.53%
Yearly
16.65%
Q1 Forecast
10.13

Omeros reported $69.65M in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Adma Biologics USD 466.51M 63.86M Dec/2025
Alnylam Pharmaceuticals USD 4.05B 97.85M Dec/2025
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Cytokinetics USD 916.97M 60.37M Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
Heron Therapeutics USD 238.07M 8.67M Dec/2025
Immunic USD 39.27M 20.57M Sep/2025
Insmed USD 1.79B 137.6M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
MacroGenics USD 219.94M 12.15M Dec/2025
Omeros USD 69.65M 26.53M Jun/2025
Pacira USD 547.97M 14.78M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Rockwell Medical USD 31.61M 1.42M Jun/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sarepta Therapeutics USD 2.54B 184.37M Dec/2025
United Therapeutics USD 3.7B 208.5M Dec/2025
Vertex Pharmaceuticals USD 11.2B 631.4M Dec/2025
Xoma USD 110.71M 5.78M Sep/2025